top of page
CPT CODE | PROCEDURE | PRICE |
|---|---|---|
0 | CT LIVER PELVIS w/ & w/o contrast, | 0 |
0 | CT UROGRAM w/ & w/o contrast | 0 |
73700 | CT LOWER EXTREMITY w/o contrast | 0 |
73701 | CT LOWER EXTREMITY w/ contrast | 0 |
73702 | CT LOWER EXTREMITY w/ & w/o contrast | 0 |
72131 | CT LUMBAR SPINE w/o contrast | 0 |
72132 | CT LUMBAR SPINE w/ contrast | 0 |
G0297 | CT LUNG SCREENING w/o contrast | 0 |
70486 | CT MAXILLOFACIAL w/o contrast | 0 |
70490 | CT NECK SOFT TISSUE w/o contrast | 0 |
TEST ID | Test Name | CPT Code |
|---|---|---|
AHUSD | Atypical Hemolytic Uremic Syndrome Complement Panel, Serum and Plasma | 86160 x 7
86161
86162 |
OLIGU | Oligosaccharide Screen, Random, Urine | 84377 |
RBCME | Red Blood Cell Membrane Evaluation, Blood | 85557-Osmotic fragility
88184-Flow cytometry; first cell surface, cytoplasmic or nuclear marker x 1
85060-Morphology review |
LDALD | Lysosomal and Peroxisomal Disorders Newborn Screen, Blood Spot | 83789 |
CHFXH | Chromosome Analysis, Hematologic Disorders, Fixed Cells | 88291
88264 w/modifier 52 (if appropriate)
88264 (if appropriate)
88264, 88285 (if appropriate)
88283 (if appropriate) |
EZNT8 | Zinc Transporter 8 (ZnT8) Antibody, Serum | 86341 |
NR4A3 | NR4A3 (9q22.33) Rearrangement, FISH, Tissue | 88271 x 2, 88291-DNA probe, each (first probe set), Interpretation and report
88271 x 2-NA probe, each; each additional probe set (if appropriate)
88271 x 1-DNA probe, each; coverage for sets containing 3 probes (if appropriate)
88271 x 2-DNA probe, each; coverage for sets containing 4 probes (if appropriate)
88271 x 3-DNA probe, each; coverage for sets containing 5 probes (if appropriate)
88274 w/modifier 52-Interphase in situ hybridization, |
MSMRT | Mayo Algorithmic Approach for Stratification of Myeloma and Risk-Adapted Therapy Report, Bone Marrow | 88182-Flow cytometry, cell cycle or DNA analysis
88184-Flow cytometry; first cell surface, cytoplasmic or nuclear marker
88185 x 5-Flow cytometry; additional cell surface, cytoplasmic or nuclear marker (each)
88187-Flow cytometry interpretation, 2 to 8 Markers |
HCQ | Hydroxychloroquine, Serum | 80220 |
BMIYC | Borrelia miyamotoi Detection PCR, Spinal Fluid | 87478 |
TFEBF | Renal Cell Carcinoma, 6p21.1 (TFEB) Rearrangement, FISH, Tissue | 88271 x 2, 88291-DNA probe, each (first probe set), Interpretation and report
88271 x 2-DNA probe, each; each additional probe set (if appropriate)
88271 x 1-DNA probe, each; coverage for sets containing 3 probes (if appropriate)
88271 x 2-DNA probe, each; coverage for sets containing 4 probes (if appropriate)
88271 x 3-DNA probe, each; coverage for sets containing 5 probes (if appropriate)
88274 w/modifier 52-Interphase in situ hybridization, |
BILHA | Schistosoma species Antibody, IgG, Serum | 86682 |
bottom of page